Three Drug Makers Cite Aurobindo For Infringing Patents With One Drug
This article was originally published in PharmAsia News
Executive Summary
Hospira, Kowa and Medicines Company each have filed petitions in a U.S. court alleging a single Aurobindo Pharma generic product infringed on their patents for three separate drugs, none for the same indication.